Legal & General Group PLC Aytu Biopharma, Inc Transaction History

Legal & General Group PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$4.73 - $7.56 $8,334 - $13,320	-1,762 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.23 - $9.88 $9,176 - $14,553	1,473 Added 509.69%	1,762 $13,000
Q4 2020 Feb 12, 2021	BUY	$5.98 - $13.5 $1,728 - $3,901	289 New	289 $2,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $88.7M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.